NATIONAL JEWISH HEALTH
1400 Jackson Street, Denver, CO 80206 www.njhealth.org

---

Organizations Filed Purposes: National Jewish Health's mission since 1899 is to heal, discover and educate as a preeminent healthcare institution. We serve by providing the best integrated and innovative care for patients and their families; by understanding and finding cures for the diseases we research; and, by educating and training the next generation of healthcare professionals to be leaders in medicine and science.

National Jewish Health is a nationally recognized, academic medical center with specialized expertise in the evaluation and management of respiratory, cardiac, allergic and immunologic diseases. National Jewish serves as a referral center for patients across the United States, particularly for those patients with diseases that are exceptionally difficult to diagnose and/or treat. National Jewish provides care to adult and pediatric patients on both an inpatient and outpatient basis and offers a comprehensive spectrum of clinical services. Clinical services include but are not limited to: pulmonary, critical care and sleep medicine, allergy/immunology, occupational and environmental health sciences, cardiology, pulmonary hypertension, rheumatology, gastroenterology, infectious disease and mycobacterial infections, cystic fibrosis, neurology, neuromuscular medicine and ALS, thoracic surgery, otolaryngology and oncology. In the fiscal year ended June 30, 2019, National Jewish Health provided over 110,000 outpatient visits. Additionally, our physicians provided over 23,790 inpatient encounters, primarily critical care services, pulmonary consultative service and hospitalist services, at multiple facilities across metropolitan Denver, including the National Jewish Health main campus. Our patients come from virtually every state from across the United States, with residents from our Colorado community constituting the largest single group. National Jewish Health was founded under the motto, "none May enter who can pay; None can pay who enter." While today, National Jewish Health accepts paying patients, we still provide significant amounts of charity care and offer all appointments on a first come, first serve basis regardless of the ability to pay. National Jewish Health also provides 340b drugs to our patients at a lower cost through pharmacy retail stores. National Jewish Health has partnered with a local hospital to provide a combined state of the art Outpatient Clinic and Inpatient care setting.

National Jewish Health receives various types of grants. In addition to the above, National Jewish Health received $47,661,268 of funding through grants which are included on Part VIII (revenues), line 1e. This includes NIH grants of $39,246,338. National Jewish Health conducts extensive basic, translational and clinical biomedical research. In addition to translational research programs in its areas of clinical specialties, National Jewish Health conducts research in basic immunology, genetics, proteomics, cell biology, signal transduction, structural biology, cancer biology, and oxidant biology. Research activities have resulted in a number of scientific discoveries that have improved care for patients worldwide. National Jewish played an important role in the unveiling of a promising 3 drug therapy for Cystic Fibrosis Patients. This new therapy could benefit 90% of patients with the disease. Funds for National Jewish Health's biomedical research are provided by grants from private and governmental agencies which include the National Institutes of Health (NIH), the Department of Defense (DOD), National Science Foundation (NSF); and charitable contributions.

National Jewish Health is the nation's largest nonprofit provider of phone-based commercial tobacco cessation services, delivering evidence-based, personalized telephone and online coaching programs in 18 states and for more than 150 health plans, employer groups, and wellness companies. The state grant contract revenue of $13,285,514 is included in Part VIII line 1e, while the rest of the revenue is reported above. Since the development of our Quitline program in 2002, we have assisted more than 1.5 million people with their quit attempts. We leverage emerging research and some of the industry's most prominent thinkers to continually adapt and improve our program in order to meet the needs of our clients and participants. The Quitline program follows the best practices and industry standards published by the Centers for Disease Control and Prevention (CDC) and North American Quitline Consortium (NAQC). Our protocols are research- and evidence-based. The Quitline is staffed by more than 100 professionals who are devoted to commercial tobacco use prevention and cessation. Our Tobacco Cessation Coaches (Coaches) undergo rigorous training that enables them to tailor their coaching services based on participant needs using our proven-successful coaching model. For each person who reaches out to the quitline for help, we immediately engage them in their quit journey to foster success, and our results demonstrate our proven track record. Our surveys, conducted by an independent third party, show that individuals who receive our evidence-based coaching services and use cessation medications have a 39% long-term quit rate-one of the best quit rates in the nation.

---

---

Data for this page was sourced from XML published by IRS (public 990 form dataset) from: https://s3.amazonaws.com/irs-form-990/202011559349300711_public.xml